Researcher
Geert ROBAEYS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Immunology not elsewhere classified
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Aug 2009 → Today - Immunology - Biochemistry (Research group)
Member
From1 Sep 2012 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Aug 2009 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Aug 2009 → 30 Sep 2009
Projects
1 - 6 of 6
- Development of an evidence based proof of concept care path for Non-Alcoholic Fatty Liver disease in Flanders.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- The effectiveness and cost-efficacy of different guidance methods to facilitate lifestyle changes in the treatment of NAFLDFrom1 Oct 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- : Development of an evidence based proof of concept care path for Non-Alcoholic Fatty Liver disease in Flanders.From1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Viral hepatitis B in EU regional setting: prevalence, risk factors and disease progression among migrants.From1 Oct 2016 → 30 Sep 2020Funding: BOF - Doctoral projects
- HCV treatments as prevention in Europe: model projections of impact and strengthening evidence base on intervention coverage and effect and HCV morbidityFrom27 Jun 2014 → 30 Sep 2015Funding: Other EU initiatives out of framework, Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 93
- Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groups(2019)
Authors: L. Opstaele, Rob BIELEN, S. Bourgeois, C. Moreno, F Nevens, Geert ROBAEYS, H. Van Vlierberghe
Pages: 379 - 387 - The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection.(2019)
Authors: Ozgur KOC, Geert ROBAEYS, Beytullah Yildirim, Dirk Posthouwer, Niel HENS, Ger H. Koek
Pages: 623 - 629 - Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium A protocol for screening(2019)
Authors: Ozgur KOC, Niel HENS, Rob BIELEN, Pierre Van Damme, Geert ROBAEYS
- Long-term outcome in Caucasian patients with hepatitis B e antigen-negative chronic infection: An observational cohort study(2019)
Authors: Ozgur KOC, Geert ROBAEYS, Rob BIELEN, Dana BUSSCHOTS, Ger Koek, Frederik Nevens
Pages: E260 - E260 - Addressing the hepatitis C care continuum: towards viral eradication(2019)
Authors: Rob BIELEN, Geert ROBAEYS
Number of pages: 231 - Hepatitis C care among persons who use or inject drugs(2019)
Authors: Amber ARAIN, Geert ROBAEYS
Number of pages: 188 - A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016(2019)
Authors: S. Bourgeois, J. P. Mulkay, L. Lasser, Geert ROBAEYS, B. Bastens, J. Delwaide, S. Pollet, M. Van den Enden
Pages: 43 - 52 - Screening for hepatitis C at the emergency department: Babyboomers should also be screened in Belgium(2018)
Authors: Rob BIELEN, Cécile KREMER, Ozgur KOC, Diana HENDRICKX, Pascal VANELDEREN, Niel HENS, F. Nevens, Geert ROBAEYS
Pages: S322 - S323 - Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study(2018)
Authors: Rob BIELEN, Geert ROBAEYS, Sigrid Schelfhout, Diethard Monbaliu, Schalk Van der Merwe, Jacques Pirenne, Frederik Nevens
Pages: 503 - 509 - Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes(2018)
Authors: S. Van Hees, S. Bourgeois, Hans Van Vlierberghe, T. Serste, S. Francque, P. Michielsen, D. Sprengers, H. Reynaert, J. Henrion, S. Negrin Dastis, et al.
Pages: 1170 - 1180
Linked dataset
1 - 1 of 1